関連する実験動画
Updated: Jul 16, 2026
13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
ポリアルテライトス・ノドーサ (Polyarteritis nodosa) とは
1Division of Rheumatology, Johns Hopkins Vasculitis Center, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. jstone@jhmi.edu
JAMA
|September 28, 2002
まとめ
血管炎の一種である多動脈炎ノドーサ (PAN) の診断は困難である可能性があります. このケースは,成人発症のスティル病の誤診が10年続いた後,サイクロフォスファミドによる治療が成功したことを強調しています.
科学分野:
- レウマトロジーの病理学
- 血管炎 (Vasculitis) とは,血管炎 (Vasculitis) とは,血管炎 (Vasculitis) とは,血管炎 (Vasculitis) とは,
- 免疫抑制療法による免疫抑制療法
背景:
- ポリアテライトス・ノドーサ (PAN) は,珍しい全身性血管炎です.
- 血管炎における診断上の課題は,治療の遅延につながる可能性があります.
- PANの歴史的文脈,クスマールとメイヤーの最初の記述を参考にする.
研究 の 目的:
- 成人発症ポリアテライトス・ノドーサ (PAN) の複雑な症例を提示するために.
- 血管炎における診断上の課題を図解し,特に,PANと成人発症のスティル病を区別する.
- 耐火性PANの寛解を達成するために,サイクロフォスファミドとプレドニゾンの長期的な有効性を強調する.
主な方法:
- 30歳の男性で12年の症状歴がある症例報告です.
- 発熱,低心率,皮膚潰瘍,多発性単尿管炎を含む臨床表現のレビュー.
- プレドニゾンに対する治療反応の分析と,その後のサイクロフォスファミドの追加.
主要な成果:
- 患者は10年間の誤診を経験し,当初は成人発症のスティル病の治療を受けた.
- プレドニソンの治療にサイクロフォスファミドを加えた結果,初めて持続的な寛解が認められた.
- 患者は最終的にすべての免疫抑制薬を中止することができました.
結論:
- このケースは,長期的な原因不明の全身性炎症と血管性特徴を有する患者のPANを検討することの重要性を強調しています.
- サイクロフォスファミドを含む積極的な免疫抑制療法により,難しいPAN症例では長期的な寛解につながる可能性があります.
- PANの成功管理は,免疫抑制薬の最終的な中止を可能にする可能性があります.
関連する概念動画
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:22Pericarditis I: Introduction
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...